Waters new Rapid Screening-DSC enables up to 24x faster thermal stability testing at ultra-low sample volumes for antibody drugs

FHS
July 24, 2024
11:36 am

Waters Corporation announced today the global release of the TA Instruments™ Rapid Screening-Differential Scanning Calorimeter (TA Instruments RS-DSC), designed for biopharmaceutical developers. The TA Instruments RS-DSC is a high-throughput DSC for precise thermal stability testing of high-concentration biologic formulations specifically for antibody drugs and engineered proteins

Moving from crisis response to crisis prevention in U.S. mental health systems

Despite widespread promises of reform after the murder of George Floyd in 2020, in 2023, police killed at least 1,246 people — the most in

February 8, 2024

Eisai subsidiary nabs Japan rights for schizophrenia drug; Novavax’s $50M milestone

Plus, news about Candel, Inovio and RemeGene: Eisai licenses Newron Pharmaceuticals’ evenamide: Eisai’s subsidiary EA Pharma will pay up to €117 million ($123 million) …

December 14, 2024

FDA revokes EUAs of Pfizer/BioNTech’s and Moderna’s original Covid-19 vaccines – Pharmaceutical Technology

The EUAs for the bivalent original/Omicron BA.1 vaccines by Pfizer/BioNTech and Moderna were revoked by the FDA in August 2022. Credit: Wolfilser / Shutterstock.com. The

May 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.